Collaborative HIV Paediatric Study
CHIPS is a multi-centre cohort study of HIV infected children in the UK and Ireland
What is this study about?
CHIPS is a follow up study of HIV-infected children under care in the UK and Ireland. CHIPS aims to enhance the exchange of information and expertise between clinics in order to promote standardised high quality paediatrician-led care of all HIV-infected children in the UK and Ireland. Its objectives are to describe clinical, laboratory and treatment information in HIV infected children under care in the UK and Ireland, and to describe the use of paediatric HIV services. This information is fed back to the reporting paediatricians in order to inform and improve care provision.
Type of study
Who is funding the study?
CHIPS is funded by the NHS London Specialised Commissioning Group and has in the past received additional support from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen, Roche and ViiV Healthcare.
When is it taking place?
CHIPS is an ongoing cohort study which was established in April 2000.
Where is it taking place?
CHIPS is taking place in 56 (June 2015) clinics throughout the UK and Ireland. This figure includes all the London hospitals who treat HIV-infected children.
Who is included?
The National Study of HIV in Pregnancy and Childhood, at the Institute of Child Health, notifies CHIPS of any children with confirmed HIV infection, and for each of these children a baseline CHIPS questionnaire is sent to the respective clinic for completion. Thereafter, a follow-up questionnaire is sent to the clinic annually.